Molecular docking analysis of flavonoids with aldose reductase

Bioinformation. 2022 Mar 31;18(3):80-83. doi: 10.6026/97320630018180. eCollection 2022.

Abstract

Diabetes mellitus is a group of metabolic disorders that has risen to become the third most common cause in humans in recent years. The development of new bioactive substances from natural sources is a relatively new area. Flavonoids are believed to have a variety of beneficial properties in nature, including anti-inflammatory, antimicrobial, anticancer, antioxidant, neuroprotective, and anti-HIV properties. 15 naturally occurring flavonoids docked with the selected target aldose reductase. We report the optimal binding of Acumitin, Agathisflavone, Agehoustin B, and alpha-Toxicarol with aldose reductase for further consideration in drug discovery for T2DM.

Keywords: Diabetes; aldose reductase; flavonoids; molecular docking.